ssri
22 interactions related to ssri
St. John's Wort + SSRI
St. John's Wort is pharmacologically active, not a harmless herb, and it interacts with SSRIs in two overlapping and hard-to-predict ways. The result is a combination most clinicians prefer to avoid rather than manage.
sertraline + st. john's wort
Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently raises central serotonin through constituents such as hyperforin and hypericin. Combining them can trigger serotonin syndrome, a potentially life-threatening reaction marked by altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also induces CYP3A4 and CYP2C19, which can lower sertraline levels and undermine treatment.
sertraline + 5-htp
Sertraline blocks serotonin reuptake and 5-HTP (5-hydroxytryptophan) is the immediate precursor of serotonin, so it directly increases serotonin synthesis. Combining the two stacks production and reuptake blockade, which can precipitate serotonin syndrome.
fluoxetine + sam-e
SAM-e has its own serotonergic and mood-elevating activity, so combining it with fluoxetine can add to your overall serotonin tone. In theory this can raise the risk of serotonin syndrome, and in vulnerable people it can tip mood into hypomania or mania. Because fluoxetine clears slowly, this caution lingers for weeks after the last dose. The evidence is mostly case reports involving other antidepressants and general guidance about combining SAM-e with serotonin-raising drugs, rather than fluoxetine-specific data.
fluoxetine + kava
Kava carries a well-documented risk of serious, unpredictable liver injury and acts as a central nervous system depressant, so combining it with fluoxetine raises concern about additive sedation and liver harm. Kava also inhibits the liver enzymes that clear fluoxetine, though this has only been shown in laboratory studies and any rise in fluoxetine levels in people remains theoretical.
fluoxetine + tryptophan
Fluoxetine blocks serotonin reuptake while tryptophan supplies the raw material for serotonin synthesis, and the combination can produce an excitatory reaction or serotonin syndrome. Fluoxetine's long-acting active metabolite means this risk persists for weeks after the last dose.
sertraline + kava
Kava (Piper methysticum) is a central nervous system depressant with a documented risk of serious liver injury, and combining it with sertraline raises the chance of additive sedation and additive liver stress. Kava also inhibits drug-metabolizing enzymes, and a case report describes prolonged serotonin syndrome in a patient taking kava alongside a serotonergic antidepressant.
fluoxetine + saffron
Saffron (Crocus sativus) has its own mild antidepressant activity, including serotonergic effects shown in randomized controlled trials. Combining a standardized saffron extract with fluoxetine theoretically adds to serotonergic tone, but augmentation trials adding saffron on top of existing antidepressants found it well tolerated, with no reported cases of serotonin syndrome. The interaction is best treated as plausible rather than documented.
fluoxetine + st. john's wort
Fluoxetine and St. John's wort both increase serotonin activity, and combining them can add to the same effect and contribute to serotonin syndrome.
paroxetine + st. john's wort
Paroxetine is an SSRI that raises serotonin by blocking its reuptake. St. John's wort independently raises serotonin and also induces drug-metabolizing enzymes and P-glycoprotein. Taken together, the additive serotonin effect can precipitate serotonin syndrome, and paroxetine is among the most frequently implicated SSRIs in published St. John's wort case reports.
saffron + antidepressants
Saffron's active constituents (crocin and safranal) show antidepressant-like activity in laboratory and animal studies, partly through monoamine reuptake and monoamine-oxidase inhibition. This overlaps with how SSRIs, SNRIs, and MAOIs work, raising a theoretical concern about additive serotonergic effects. In practice, human trials combining standardized saffron with fluoxetine or sertraline reported no serotonin syndrome and no serious adverse events, and there are no documented human cases from this combination.
sertraline + sam-e
SAM-e (S-adenosyl-L-methionine) has its own antidepressant and serotonergic activity, so combining it with the SSRI sertraline can add serotonergic effects on top of each other. Case reports describe serotonin-toxicity-like presentations and treatment-emergent mania in patients combining SAM-e with serotonergic antidepressants.
caffeine + sertraline
Caffeine and sertraline do not share a receptor, but their side-effect profiles overlap. Both can cause anxiety, jitteriness, insomnia, stomach upset and headache, so these symptoms can stack — most noticeably during the first few weeks of sertraline treatment. Unlike fluvoxamine, sertraline does not meaningfully slow caffeine clearance.
cbd + sertraline
CBD inhibits CYP2C19, one of several enzymes that help break down sertraline, so adding CBD can raise sertraline exposure. A single published case report describes low sodium (hyponatremia) and cognitive decline in an older intermediate-metabolizer patient who added over-the-counter CBD to long-standing sertraline. The evidence is limited to this one report, so treat it as a reason for caution and prescriber discussion rather than a strong contraindication.
cannabis + ssris
Cannabinoids inhibit liver enzymes (including CYP2C19) that clear several SSRIs such as sertraline, citalopram, and escitalopram, which can raise SSRI plasma levels. Cannabinoids also touch the serotonin system, and case reports describe serotonin syndrome precipitated by high-potency cannabis in patients on serotonergic regimens.
coffee + sertraline
Sertraline is a weak inhibitor of CYP1A2, the enzyme that clears caffeine, so it can slow caffeine metabolism mildly. More relevant in practice, caffeine can add to the jitteriness, palpitations, anxiety, and insomnia that often appear in the first weeks of sertraline. The pharmacokinetic effect is far smaller than with fluvoxamine and is usually minor.
fluoxetine + 5-htp
Fluoxetine is an SSRI that blocks serotonin reuptake, and 5-HTP is a direct precursor the body converts into serotonin. Combining them can push serotonin to levels associated with serotonin syndrome, and fluoxetine's long-lived active metabolite norfluoxetine extends this risk for weeks after the last dose.
escitalopram + st. john's wort
Escitalopram is a selective SSRI cleared mainly by CYP2C19 and CYP3A4. St. John's wort independently raises serotonin tone and is a strong inducer of those same enzymes and P-glycoprotein. Taken together, the combination can add to serotonergic effects and, through enzyme induction, lower escitalopram levels and blunt its antidepressant effect. Documented serotonin syndrome cases with St. John's wort involve other SSRIs rather than escitalopram specifically, so the combination is best avoided rather than treated as a guaranteed emergency.
alcohol + sertraline
Sertraline (Zoloft) and alcohol both act on the central nervous system. Controlled studies in healthy volunteers did not show sertraline worsening alcohol's effects on thinking or coordination, but the FDA label still advises against drinking on sertraline because alcohol can deepen depression and anxiety, worsen drowsiness and sleep, and blunt the medication's benefit in people being treated for a mood disorder.
alcohol + fluoxetine
Fluoxetine (Prozac) is an SSRI antidepressant, and alcohol is a central nervous system depressant. The FDA-approved Prozac label states that alcohol use is not recommended while taking fluoxetine. Fluoxetine and its active metabolite norfluoxetine also have unusually long half-lives, so the drug stays in your system for weeks once you reach steady state — there is no simple "timing window" that avoids the interaction. Notably, a controlled human study found that alcohol did not measurably increase fluoxetine's psychomotor impairment, so the combined sedative effect is more modest than once assumed; the precaution remains sensible but is not an emergency.
sertraline + tryptophan
Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin signaling, and L-tryptophan is the dietary precursor your body converts into serotonin. Taking them together can push serotonergic activity too high, raising the risk of serotonin syndrome (agitation, tremor, sweating, fast heart rate, and in severe cases fever, rigidity, and seizures).
coffee + antidepressants
Some antidepressants slow how fast the body clears caffeine by inhibiting the liver enzyme CYP1A2 — fluvoxamine does this most strongly, while fluoxetine, sertraline, paroxetine, and duloxetine have milder effects. At the same time, caffeine independently worsens anxiety, insomnia, tremor, and a racing heart, the very symptoms antidepressants are often prescribed to relieve. With MAOIs, very high caffeine intake has been linked in case reports to blood pressure spikes.